Search
Search Results
##search.searchResults.foundPlural##
-
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1776PDF: 880HTML: 932Referring article: 718 -
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1160PDF: 928HTML: 192 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2737PDF: 899HTML: 7301 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1525PDF: 549HTML: 213 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1601PDF: 1129HTML: 229 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3430PDF: 2344HTML: 1411 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3244PDF: 1208HTML: 2176 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
675PDF: 389HTML: 70 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1116PDF: 802HTML: 2164Figue 1: 158 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3765PDF: 3088HTML: 186 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1229PDF: 587HTML: 3059 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1933PDF: 1367HTML: 247 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1666PDF: 603HTML: 1498Figure 1: MRI demonstrating Aspergillus synovitis: 166Figure 2:MRI demonstrating Aspergillus synovitis: 163 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2013PDF: 1087HTML: 7671cover letter paper final AML: 192 -
-
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2401PDF: 760HTML: 1721 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1958PDF: 767HTML: 1026 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1664Suppl. Files: 830HTML: 403PDF: 707 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1337PDF: 797HTML: 3103 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1758PDF: 830HTML: 3581Diamond Blackfan Anemia: A Tertiary care centre experience: 230 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4561PDF: 1282HTML: 1888Untitled: 165Untitled: 163 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8877PDF: 5959HTML: 87459Fig.1b: 164Fig.1c: 165Fig.2a: 156Fig.2b: 161Fig.4: 169Fig.2c: 158Fig.3: 163Tab.1: 212Tab.2: 191Tab.3: 177Tab.4: 199Fig1a: 158







